Clinical Trial Update: EACH: Evaluating Avelumab in Combination With Cetuximab in Head and Neck Cancer [Phase 2]

View source ↗

Summary

This is a Phase 2 trial update evaluating the combination of avelumab and cetuximab for head and neck squamous cell carcinoma, sponsored by University College L…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• BAVENCIO (AVELUMAB)
• ERBITUX (cetuximab)

Snippet

Sponsor: University College, London | Conditions: Head and Neck Cancer, Squamous Cell Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING